7 results
Atopic Dermatitis - Topical Treatment Options 
First Line: Topical Corticosteroids 
  - High Potency: Betamethasone
Dermatitis - Topical Treatment ... therapy is non-pharmacologic ... If patients using ... Dermatitis #Topical #Treatment ... #Dermatology #Management
Perioperative Management of DOACs
Problem:
 ✖ Each year approximately 250,000 patients on chronic anticoagulation in North America
Perioperative Management ... clearance (calculated using ... interruption per treatment ... direct thrombin inhibitor ... #Treatment #pharmacology
Hemophagocytic Lymphohistiocytosis (HLH)
Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
Lymphohistiocytosis (HLH) Pathophysiology ... Anti-infectious, chemotherapy ... Anti-IFN-y and JAK inhibitors ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
leukocytosis, psychiatric ... or arrhythmia) during ... monoamine oxidase inhibitors ... (chemotherapy, ... #treatment
Allopurinol Pharmacology Summary

Xanthine oxidase inhibitor blocking the formation of new uric acid
Initiate 1-2 days prior to
Allopurinol Pharmacology ... Xanthine oxidase inhibitor ... days prior to chemotherapy ... Dosing: 100 mg ... #pathophysiology
Methotrexate Toxicology 

Intravenous leucovorin (folinic acid) treatment serves as a cofactor necessary for synthesis of thymidylate
(folinic acid) treatment ... ineffective because MTX inhibits ... Leucovorin dosing ... Toxicology #Toxicity #Management ... #Pharmacology
Management of Anthracyclines and HER2 Antagonist Cardiotoxicity
Anthracyclines cause cardiomyopathy:
 ✖ Reduction in left ventricular ejection fraction
Management of Anthracyclines ... ) and initiate treatment ... every 3 months during ... cardiology #oncology #pharmacology ... #toxicity #chemotherapy